A well-connected family’s fight to access a potential treatment for their son highlights the barriers most rare disease ...
Researchers have taken an important step toward solving one of the biggest challenges in gene therapy for children with ...
U.S. Rare Disease Genome Editing Market to Reach USD 3.60 Billion and Europe USD 3.42 Billion by 2035 as CRISPR Adoption, ...
Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité (BIH) and Genomics England have ...
All life on Earth shares a common ancestor that lived roughly four billion years ago. This so-called "last universal common ancestor" (LUCA) represents the most ancient organism that researchers can ...
An international team of researchers led by the University Hospital and University of Bonn, as well as the universities of ...
Newsable Asianet News on MSN
RARE Stock Jumps 6% After-Hours On First Gene Therapy Approval, New Priority Review Voucher
The FDA granted accelerated approval to GENGLYCOS, also called DTX401, for patients aged eight and older with glycogen storage disease type Ia (GSDIa).
The Long Life Family Study (LLFS) is a multi-decade, multicenter research program designed to uncover the genetic and biological factors that contribute to exceptional human longevity and healthy ...
A single one-time gene therapy could free patients with α-thalassemia, a rare and debilitating blood disorder, from the burden of lifelong transfusions. A single one-time gene therapy could free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results